Gilead Sciences
GILD
#83
Rank
S$270.61 B
Marketcap
S$218.06
Share price
3.06%
Change (1 day)
39.97%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): -S$2.6 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are S$30.45 Billion. In 2025 the company made an earning of S$12.51 Billion, an increase over its 2024 earnings that were of S$0.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$2.6 Billion-120.7%
2025 S$12.51 B1319.86%
2024 S$0.88 B-89.94%
2023 S$8.76 B17.97%
2022 S$7.42 B-29.77%
2021 S$10.57 B395.99%
2020 S$2.13 B-67.66%
2019 S$6.59 B-33.84%
2018 S$9.96 B-42.35%
2017 S$17.28 B-20.87%
2016 S$21.84 B-21.06%
2015 S$27.67 B45.8%
2014 S$18.97 B253.01%
2013 S$5.37 B16.51%
2012 S$4.61 B-1.07%
2011 S$4.66 B-6.71%
2010 S$4.99 B11.75%
2009 S$4.47 B29.5%
2008 S$3.45 B19.11%
2007 S$2.90 B-455.74%
2006 -S$0.82 Billion-154.93%
2005 S$1.48 B76.99%
2004 S$0.83 B-266.16%
2003 -S$0.51 Billion-638.24%
2002 S$93.77 M31.5%
2001 S$71.31 M-242.15%
2000 -S$50.17 Million-40.2%
1999 -S$83.89 Million31.85%
1998 -S$63.63 Million8.73%
1997 -S$58.52 Million27.22%
1996 -S$46 Million
1994 -S$43.83 Million26.57%
1993 -S$34.63 Million46.49%
1992 -S$23.64 Million362.5%
1991 -S$5.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.48 B-1,440.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.82 B-453.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$11.11 B-544.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$42.92 B-1,818.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$13.14 B-626.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$1.29 B-151.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.48 B-159.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$6.44 B-358.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.82 B-493.35%๐Ÿ‡บ๐Ÿ‡ธ USA